403 related articles for article (PubMed ID: 26499920)
1. Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.
Sen HN; Abreu FM; Louis TA; Sugar EA; Altaweel MM; Elner SG; Holbrook JT; Jabs DA; Kim RY; Kempen JH;
Ophthalmology; 2016 Jan; 123(1):183-90. PubMed ID: 26499920
[TBL] [Abstract][Full Text] [Related]
2. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA
JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440
[TBL] [Abstract][Full Text] [Related]
3. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
[TBL] [Abstract][Full Text] [Related]
4. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
Holbrook JT; Sugar EA; Burke AE; Vitale AT; Thorne JE; Davis JL; Jabs DA;
Am J Ophthalmol; 2016 Apr; 164():29-36. PubMed ID: 26748056
[TBL] [Abstract][Full Text] [Related]
5. Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis.
Chang IT; Gupta D; Slabaugh MA; Vemulakonda GA; Chen PP
J Glaucoma; 2016 Oct; 25(10):842-846. PubMed ID: 27300641
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
Tomkins-Netzer O; Lightman S; Drye L; Kempen J; Holland GN; Rao NA; Stawell RJ; Vitale A; Jabs DA;
Ophthalmology; 2015 Nov; 122(11):2351-9. PubMed ID: 26359188
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
8. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Louis TA; Sugar EA; Thorne JE
Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.
Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group
Ophthalmology; 2015 Oct; 122(10):1976-86. PubMed ID: 26298718
[TBL] [Abstract][Full Text] [Related]
11. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
[TBL] [Abstract][Full Text] [Related]
12. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
13. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
[TBL] [Abstract][Full Text] [Related]
14. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.
Kempen JH; Van Natta ML; Altaweel MM; Dunn JP; Jabs DA; Lightman SL; Thorne JE; Holbrook JT;
Am J Ophthalmol; 2015 Dec; 160(6):1133-1141.e9. PubMed ID: 26386159
[TBL] [Abstract][Full Text] [Related]
15. Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results.
Tomkins-Netzer O; Lightman SL; Burke AE; Sugar EA; Lim LL; Jaffe GJ; Altaweel MM; Kempen JH; Holbrook JT; Jabs DA;
Ophthalmology; 2021 May; 128(5):719-728. PubMed ID: 32918964
[TBL] [Abstract][Full Text] [Related]
16. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.
Callanan DG; Jaffe GJ; Martin DF; Pearson PA; Comstock TL
Arch Ophthalmol; 2008 Sep; 126(9):1191-201. PubMed ID: 18779477
[TBL] [Abstract][Full Text] [Related]
17. Fluocinolone acetonide intravitreal implant (Retisert
Leinonen S; Immonen I; Kotaniemi K
Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results.
Jain N; Stinnett SS; Jaffe GJ
Ophthalmology; 2012 Jan; 119(1):132-7. PubMed ID: 21924503
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.
Sugar EA; Venugopal V; Thorne JE; Frick KD; Holland GN; Wang RC; Almanzor R; Jabs DA; Holbrook JT;
Ophthalmology; 2017 Nov; 124(11):1662-1669. PubMed ID: 28624167
[TBL] [Abstract][Full Text] [Related]
20. Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony.
Dayani PN; Chow J; Stinnett SS; Jaffe GJ
Am J Ophthalmol; 2011 Nov; 152(5):849-56.e1. PubMed ID: 21794844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
